Ashwin Kumar Narasimhan

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 14

Top Topics

Sensitive Detection

Top Venues

Nanomedicine (London, England)

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Srushti Tambe, Rohit Kumar, Purnima Amin, Monalisa Mishra, Madhu Gupta, Kavitha Govarthanan, Ashwin Kumar Narasimhan, Piyush Kumar Gupta
Current aspects of organoid technology for biomaterial toxicity analysis. Future medicinal chemistry 15 (7) (2023)
Srushti Tambe, Rohit Kumar, Purnima Amin, Monalisa Mishra, Madhu Gupta, Kavitha Govarthanan, Ashwin Kumar Narasimhan, Piyush Kumar Gupta
Current aspects of organoid technology for biomaterial toxicity analysis. Future medicinal chemistry 15 (7) (2023)
Srushti Tambe, Rohit Kumar, Purnima Amin, Monalisa Mishra, Madhu Gupta, Kavitha Govarthanan, Ashwin Kumar Narasimhan, Piyush Kumar Gupta
Current aspects of organoid technology for biomaterial toxicity analysis. Future medicinal chemistry 15 (7) (2023)
Hema Brindha Masanam, Govindaraj Perumal, Saravanan Krishnan, Sachin Kumar Singh, Niraj Kumar Jha, Dinesh Kumar Chellappan, Kamal Dua, Piyush Kumar Gupta, Ashwin Kumar Narasimhan
Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases. Nanomedicine (London, England) 17 (25) (2023)
Srushti Tambe, Rohit Kumar, Purnima Amin, Monalisa Mishra, Madhu Gupta, Kavitha Govarthanan, Ashwin Kumar Narasimhan, Piyush Kumar Gupta
Current aspects of organoid technology for biomaterial toxicity analysis. Future medicinal chemistry (2023)
Hema Brindha Masanam, Govindaraj Perumal, Saravanan Krishnan, Sachin Kumar Singh, Niraj Kumar Jha, Dinesh Kumar Chellappan, Kamal Dua, Piyush Kumar Gupta, Ashwin Kumar Narasimhan
Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases. Nanomedicine (London, England) 17 (25) (2023)
Hema Brindha Masanam, Govindaraj Perumal, Saravanan Krishnan, Sachin Kumar Singh, Niraj Kumar Jha, Dinesh Kumar Chellappan, Kamal Dua, Piyush Kumar Gupta, Ashwin Kumar Narasimhan
Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases. Nanomedicine (London, England) 17 (25) (2023)
Hema Brindha Masanam, Govindaraj Perumal, Saravanan Krishnan, Sachin Kumar Singh, Niraj Kumar Jha, Dinesh Kumar Chellappan, Kamal Dua, Piyush Kumar Gupta, Ashwin Kumar Narasimhan
Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases. Nanomedicine (London, England) (2023)
Hema Brindha Masanam, Govindaraj Perumal, Saravanan Krishnan, Sachin Kumar Singh, Niraj Kumar Jha, Dinesh Kumar Chellappan, Kamal Dua, Piyush Kumar Gupta, Ashwin Kumar Narasimhan
Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases. Nanomedicine (London, England) 17 (25) (2023)
Clyde John, Kaahini Jain, Hema Brindha Masanam, Ashwin Kumar Narasimhan, Arutselvan Natarajan
Recent Trends and Opportunities for the Targeted Immuno-Nanomaterials for Cancer Theranostics Applications. Micromachines 13 (12) (2022)
Clyde John, Kaahini Jain, Hema Brindha Masanam, Ashwin Kumar Narasimhan, Arutselvan Natarajan
Recent Trends and Opportunities for the Targeted Immuno-Nanomaterials for Cancer Theranostics Applications. Micromachines 13 (12) (2022)
Clyde John, Kaahini Jain, Hema Brindha Masanam, Ashwin Kumar Narasimhan, Arutselvan Natarajan
Recent Trends and Opportunities for the Targeted Immuno-Nanomaterials for Cancer Theranostics Applications. Micromachines 13 (12) (2022)
Clyde John, Kaahini Jain, Hema Brindha Masanam, Ashwin Kumar Narasimhan, Arutselvan Natarajan
Recent Trends and Opportunities for the Targeted Immuno-Nanomaterials for Cancer Theranostics Applications. Micromachines 13 (12) (2022)
Sai Mummareddy, Stuti Pradhan, Ashwin Kumar Narasimhan, Arutselvan Natarajan
On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy. Biosensors 11 (12) (2021)